1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Determining Static Hyperinflation in Patients with Severe Emphysema: Relation Between Lung Function Parameters and Patient-Related Outcomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Bronchoscopic lung volume reduction techniques are minor invasive treatment modalities for severely hyperinflated emphysema patients. The severity of static lung hyperinflation determines eligibility and success rate for these treatments. However, it is not exactly known what parameter should be used to optimally reflect hyperinflation. Commonly used parameters are residual volume (RV) and the RV/Total lung capacity (TLC) ratio. Other parameters reflecting hyperinflation are Inspiratory Capacity/TLC and forced vital capacity.

          Objectives

          To define which of these function parameters is the most optimal reflection of hyperinflationin in relation to patient-related outcomes.

          Methods

          In a retrospective cohort study, data from measurements during baseline visits of eight studies were pooled. Primary outcomes were RV/TLC ratio and RV as percentage of predicted (RV%pred), both measured by bodyplethysmography, compared to the patient-related outcome variables: 6-min walk distance (6MWD), the St. George’s Respiratory Questionnaire (SGRQ), and the modified Medical Research Council (mMRC).

          Results

          Two hundred seventy-four COPD patients (mean age 59 years; 66% female), FEV 1 0.74 ± 0.28 L, RV 4.94 ± 1.06 L, 6MWD of 339 ± 95 m, were included in the analysis. Significant correlations (all p < 0.01) were found between RV%pred and 6MWD ( r =  − 0.358), SGRQ ( r = 0.184), and mMRC ( r = 0.228). Also, there was a significant correlation between RV/TLC ratio and 6MWD ( r =  − 0.563), SGRQ ( r = 0.289) and mMRC ( r = 0.354). Linear regression analyses showed that RV/TLC ratio was a better predictor of patient outcomes than RV%pred.

          Conclusion

          This study demonstrates that both RV/TLC ratio and RV%pred are relevant indicators of hyperinflation in patients with severe emphysema in relation to patient-related outcomes. RV/TLC ratio is more strongly related to the patient-related outcomes than RV%pred.

          Electronic supplementary material

          The online version of this article (10.1007/s00408-020-00368-9) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: not found
          • Article: not found

          Six minute walking distance in healthy elderly subjects

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation.

            Bronchoscopic lung-volume reduction with the use of one-way endobronchial valves is a potential treatment for patients with severe emphysema. To date, the benefits have been modest but have been hypothesized to be much larger in patients without interlobar collateral ventilation than in those with collateral ventilation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.

              Endobronchial valves (EBVs) have been successfully used in patients with severe heterogeneous emphysema to improve lung physiology. Limited available data suggest that EBVs are also effective in homogeneous emphysema.
                Bookmark

                Author and article information

                Contributors
                d.j.slebos@umcg.nl
                Journal
                Lung
                Lung
                Lung
                Springer US (New York )
                0341-2040
                1432-1750
                28 June 2020
                28 June 2020
                2020
                : 198
                : 4
                : 629-636
                Affiliations
                GRID grid.4494.d, ISNI 0000 0000 9558 4598, Department of Pulmonary Diseases AA11, , University of Groningen, University Medical Center Groningen, ; Hanzeplein 1, 9713 GZ Groningen, The Netherlands
                Author information
                http://orcid.org/0000-0001-9555-3422
                Article
                368
                10.1007/s00408-020-00368-9
                7374464
                32596757
                9809fee7-e0d5-48a7-a0c5-fbfa4eeb166d
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 23 January 2020
                : 11 June 2020
                Categories
                COPD
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2020

                Respiratory medicine
                hyperinflation,emphysema,residual volume,lung volume reduction,copd
                Respiratory medicine
                hyperinflation, emphysema, residual volume, lung volume reduction, copd

                Comments

                Comment on this article